Ronald E. Elwell

Dictaphone Corp. manufactures dictation and communication recording systems to the healthcare industry. Its products include Enterprise Express, EXSpeech, Enterprise Workstation, PowerScribe, mdEssential, ichart and Straight Talk NE. The company was founded in 1881 and is headquartered in Stratford, CT

Hands-On Mobile, Inc. engages in the publication and development of social games for mobile and online platforms. Its products include games, subscription services, brand management, distribution, and porting and platform management. The firm offers global distribution brands and content from partners including activision, billboard, CBS, marvel, NBA, and world poker tour. The company was founded by Daniel Kranzler in 2001 and is headquartered in San Francisco, CA.

Part of HP, Inc., Octave Communications, Inc. provides voice conferencing equipment. The company is based in Nashua, NH. Octave Communications was acquired by Voyant Technologies, Inc., part of HP, Inc. from January 05, 2004 on January 21, 2003.

Deer Management Co. LLC (Bessemer Venture Partners) is a venture capital firm founded in 1911. The firm is headquartered in San Francisco, California.

GoTV Networks, Inc. engages in the provision of mobile media network services. The company was founded by Engel Charity Cheiky, Michael C. Chieky, Steve Fowler, Jorge Granier-Phelps and Kenn Raaf and is headquartered in Sherman Oaks, CA.

Goal.com North America, Inc. publishes sports news. The firm provides international soccer news, commentary, and entertainment through both internet and mobile platforms. The company was founded by Gianluigi Longinotti-Buitoni and Michael Simpson in 2004 and is headquartered in New York, NY.

Swoop.com, Inc. develops applications for online shopping. The company was founded by Ronald E. Elwell, Simeon Simeonov and John W. Hadl in 2011 and is headquartered in Cambridge, MA.

Part of Real Chemistry, Inc., IPM.ai is an insights as a service provider based in Cambridge, MA. IPM.ai empowers leading life sciences companies to develop and commercialize precision medicine for specialty and rare diseases. The company's system of insight utilizes granular-level longitudinal analytics, artificial intelligence, and machine learning to streamline market assessment, patient finding, treatment journey mapping, healthcare provider discovery, key opinion leader identification, and brand activation. IPM.ai's ai-powered precision medicine platform optimizes the product lifecycle for rare disease therapies to ensure optimal patient outcomes. The company was founded by Simeon Simeonov and Ronald E. Elwell, with Ronald E. Elwell serving as CEO since incorporation.